向非编码RNA来克服耐药性并改善质母细胞瘤的结果
Dhruv Parikh1,2,3, Manan Shah4
1Department of Neurology, Johns Hopkins Medicine, Baltimore, MD 21205, USA.
Global medical genetics
|December 26, 2025
概括
非编码RNAs (ncRNAs) 是质母细胞瘤 (GB) 进展和耐药性的关键调节者. 针对这些分子,包括研究不足的circRNAs和piRNAs,为这种侵略性脑瘤提供了有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 质母细胞瘤 (GB) 是一种高度攻击性的脑瘤,结果不佳.
- 瘤异质性和治疗耐药性是GB治疗的主要挑战.
- 非编码RNAs (ncRNAs) 在GB发育和进展中起着至关重要的作用.
研究的目的:
- 审查各种ncRNAs (miRNAs, lncRNAs, circRNAs, piRNAs) 在质母细胞瘤中的作用.
- 探索ncRNAs作为质母细胞瘤的生物标志物和治疗点.
- 讨论基于ncRNA的质母细胞瘤治疗的挑战和策略.
主要方法:
- 关于质母细胞瘤中ncRNAs的综合文献综述.
- 在瘤过程中 ncRNA 功能的评估 (增殖,血管生成,EMT,免疫逃避).
- 对ncRNAs的检测方法,传递技术和临床试验的分析.
主要成果:
- ncRNAs显著调节质母细胞瘤的进展,耐药性和免疫逃避.
- 循环RNAs (circRNAs) 和PIWI相互作用RNAs (piRNAs) 显示出复杂的调节作用和治疗潜力.
- 纳米载体和基于外体的输送系统显示出克服血脑屏障的希望.
结论:
- ncRNAs代表了用于质母细胞瘤精密瘤的多功能工具包.
- 针对特定的ncRNAs可以克服治疗耐药性并增强免疫疗法.
- 对代表性不足的ncRNA子类进行进一步的研究对于推进质母细胞瘤管理至关重要.
关键词:
癌症 癌症 癌症 癌症循环RNAs (循环RNAs) 是一种循环RNA.表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.质母细胞瘤 (glioblastoma) 是一个改善了结果的改善.长非编码RNAs (lncRNAs) 是一种长非编码RNA.微RNAs (miRNAs) 是一种微型RNA.神经生物学 神经生物学 神经生物学没有编码的RNAs.与PIWI相互作用的RNAs (piRNAs) 发生相互作用.治疗性耐药性是一种治疗性耐药性.更多相关视频
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.9K
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
1.0K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:15Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K